Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

stockhead.com.au - 12/Sep 03:41

Clinical-stage biotech Dimerix has achieved a key milestone with the first paediatric site opening for its ACTION3 Phase 3 clinical ...

Dimerix first patient completes Phase 3 trial and enters into long-term DMX-200 Open Label Extension study

stockhead.com.au - 10/Sep 23:38

Dimerix has enrolled the first patient into the Open Label Extension study for its kidney disease drug candidate DMX-200 after ...

First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

drugs.com - 09/Sep 20:09

HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...

Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval

stockhead.com.au - 04/Sep 20:45

Despite many obstacles, Dimerix is getting to the pointy end of things with its kidney drug trial program. ...

Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval

stockhead.com.au - 04/Sep 20:45

Despite many obstacles, Dimerix is getting to the pointy end of things with its kidney drug trial program. ...

Paradigm steps closer to Phase 3 trial for knee arthritis treatment after FDA feedback

stockhead.com.au - 04:41

Late-stage drug development company Paradigm Biopharmaceuticals has a clear pathway from the FDA for progression of its Phase 3 trial ...

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

drugs.com - 06:09

CAMBRIDGE, Mass., Sept. 18, 2024. Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary...

Rubriques :

Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

Articles similaires

Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

Dimerix first patient completes Phase 3 trial and enters into long-term DMX-200 Open Label Extension study

First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval

Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval

Paradigm steps closer to Phase 3 trial for knee arthritis treatment after FDA feedback

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

Bharat Biotech, Alopexx Inc of US to co-develop, commercialise anti-microbial vax AV0328

PharmAust seeks orphan drug designation in Europe for monepantel to treat ALS

Les derniers communiqués